Analysis: The Rich Are Skipping the Vaccine Queue. What Are We Going to Do About It?
by James Meadway
The coronavirus vaccine was never going to be entirely immune from market forces. But if we’re going to recover from this pandemic, or prevent another, we must radically rethink how we share the fruits of our scientific labours, writes James Meadway.